3645-26-9 Usage
Uses
Due to the limited information available on 10-chlorobenzo[g]quinoline, its applications are not clearly defined. However, given the biological activities often associated with benzene and quinoline compounds, it is possible that 10-chlorobenzo[g]quinoline could be used in various industries, such as:
Used in Pharmaceutical Industry:
10-chlorobenzo[g]quinoline could be utilized as a bioactive compound for the development of new drugs, potentially targeting a range of diseases and conditions due to its chemical structure and the known activities of related compounds.
Used in Chemical Research:
As a member of the benzoquinoline class, 10-chlorobenzo[g]quinoline may serve as a subject for chemical research, exploring its reactivity, stability, and potential to form new compounds or complexes with other molecules.
Used in Material Science:
10-chlorobenzo[g]quinoline's properties might be harnessed in material science for the development of new materials with specific characteristics, such as conductivity, stability, or optical properties, depending on its behavior when integrated into larger structures.
Check Digit Verification of cas no
The CAS Registry Mumber 3645-26-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,6,4 and 5 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 3645-26:
(6*3)+(5*6)+(4*4)+(3*5)+(2*2)+(1*6)=89
89 % 10 = 9
So 3645-26-9 is a valid CAS Registry Number.
3645-26-9Relevant academic research and scientific papers
MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF
-
Page/Page column 63; 67, (2008/06/13)
A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) its stereoisomers thereof, or a solvate thereof, or a prodrug thereof, or a pharmaceutically acceptable salt thereof, where Z is CONR1R2 or CH2NR1R2 and where at least one of X1 - X8 is N, and R, Ra, Rb, Rc and Rd are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.
Strained heterocyclic systems. 19. 1-azatriptycene and derivatives
Hodge Markgraf,Davis, Howard A.,Ernst, Peter S.,Hirsch, Kevin S.,Leonard, Kathryn J.,Morrison, Marlene E.,Myers, Christopher R.
, p. 183 - 188 (2007/10/02)
The preparations of 1-azatripycene (1) and its 9-chloro, 9-deutero, and 1-oxide derivatives are reported. The basicity of 1 is compared to model compounds.
